CTX Share Price Performance
zł69.80
27.80 (66.19%)
Price zł69.80
Share Pricen/a
Captor Therapeutics Spolka Akcyjna Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
CTX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Captor Therapeutics Spolka Akcyjna Key Details
About CTX
- Founded
- 2015
- Employees
- 91
- CEO
- WebsiteView website
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
